Both in Pharmaceuticals
Enveric Biosciences vs Kiora Pharmaceuticals
Over the past year ENVB returned −74.4% and KPRX returned −30.0%; their daily moves had a correlation of 0.02.
ENVB −74.4% KPRX −30.0%Growth of $1, one year, split-adjusted
| Metric | ENVB | KPRX |
|---|---|---|
| Price | $1.46 | $1.66 |
| Market cap | $6.5M | $7.3M |
| Today | −2.67% | −4.05% |
| 1 month | −0.7% | −33.6% |
| 6 months | −54.1% | −33.9% |
| Year to date | −59.8% | −15.7% |
| 1 year | −79.4% | −32.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.3M | $16.8M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 73.7% |
| Short % of float | 0.9% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).